RAPID MICRO BIOSYSTEMS, INC. financials

RPID CIK 0001380106

Source: EDGAR filings · Built 2026-06-04T02:29:40Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Free Cash Flow -31.94M -45.55M -46.96M -65.32M -58.19M -31.69M
EBITDA -44.14M -46.56M -53.46M -60.38M -45.70M -29.03M
Working Capital 42.68M 63.35M 101.43M 119.53M 199.96M 46.60M
Net Debt 3.84M -10.74M -16.94M -19.10M -178.39M -5.27M
Operating Margin -141.10% -177.96% -251.18% -368.99% -203.31% -189.96%
Net Margin -140.30% -167.16% -232.99% -354.91% -316.48% -230.63%
Return on Equity (ROE) -141.91% -62.23% -44.47% -37.04% -33.27% 29.19%
Return on Assets (ROA) -62.95% -47.76% -36.57% -31.89% -30.49% -52.97%
Current Ratio 3.31× 4.61× 6.34× 7.27× 12.01× 4.00×
Debt-to-Equity 0.72× 0.08× 0.06× 0.05× 0.00× -0.20×
Effective Tax Rate -0.09% -0.05% -0.06% 0.94% -0.12% -0.36%
Cash Conversion Ratio 0.66× 0.94× 0.86× 0.96× 0.75× 0.84×
Accruals Ratio -0.21× -0.03× -0.05× -0.01× -0.08× -0.09×
SBC % of Revenue 12.01% 13.81% 21.09% 23.46% 7.93% 3.32%
CapEx Coverage -35.30× -31.54× -23.95× -8.64× -17.02× -44.92×
Free Cash Flow Per Share $-0.71 $-1.05 $-1.09 $-1.54 $-2.94 $-88.36

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
P/S 3.86× 1.40× 1.41× 2.80× 9.06×
P/B 3.90× 0.52× 0.27× 0.29× 0.95×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Revenue from Contract with Customer, Excluding Assessed Tax 33.59M 28.05M 22.52M 17.13M 23.23M 16.08M
Research and Development Expense 13.60M 14.60M 12.82M 12.87M 9.78M 6.53M
Operating Income (Loss) -47.39M -49.92M -56.56M -63.22M -47.23M -30.54M
Income Tax Expense (Benefit) 40.00K 22.00K 31.00K -576.00K 91.00K 134.00K
Net Income (Loss) Attributable to Parent -47.12M -46.89M -52.47M -60.81M -73.52M -37.08M
Earnings Per Share, Basic $-1.05 $-1.08 $-1.22 $-1.43 $-3.94 $-126.11
Weighted Average Number of Shares Outstanding, Basic 44.68M 43.58M 43.02M 42.45M 19.78M 358,582
Earnings Per Share, Diluted $-1.05 $-1.08 $-1.22 $-1.43 $-3.94 $-126.11
Weighted Average Number of Shares Outstanding, Diluted 44.68M 43.58M 43.02M 42.45M 19.78M 358,582

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Cash and Cash Equivalents, at Carrying Value 20.03M 16.91M 24.29M 27.06M 178.39M 30.08M
Assets, Current 61.17M 80.92M 120.42M 138.58M 218.12M 62.15M
Assets 74.85M 98.17M 143.45M 190.65M 241.17M 70.00M
Long-term Debt 0 0 24.81M
Liabilities, Current 18.49M 17.57M 18.99M 19.05M 18.17M 15.54M
Long-term Debt, Excluding Current Maturities 18.90M 0
Liabilities 41.65M 22.82M 25.46M 26.48M 20.19M 45.18M
Stockholders' Equity Attributable to Parent 33.21M 75.35M 117.99M 164.17M 220.98M -127.01M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Net Cash Provided by (Used in) Operating Activities -31.06M -44.15M -45.08M -58.55M -54.96M -31.00M
Payments to Acquire Property, Plant, and Equipment 850.00K 1.36M 1.84M 6.74M 3.22M 690.00K
Net Cash Provided by (Used in) Investing Activities 14.33M 36.66M 42.15M -93.47M -13.29M -15.67M
Net Cash Provided by (Used in) Financing Activities 19.77M 203.00K 149.00K 693.00K 216.75M 64.23M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (RPID CIK 0001380106), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

PRVA

Privia Health Group, Inc.

ANNX

ANNEXON, INC.

GNLX

GENELUX CORPORATION